aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results
Management to host conference call and webcast on May 9th at 5:00 pm EDT /…
Month: May 2022
Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels…
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9
DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease
DALLAS, May 02, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a company pioneering the…
Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
Fulcrum Therapeutics to Host First Quarter 2022 Financial Results Conference Call and Webcast on Monday, May 9, 2022 at 8:00 a.m. ET
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company…
Gracell Biotechnologies to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
SAN DIEGO, Calif., and SUZHOU, China, May 02, 2022 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
Rhythm Pharmaceuticals Presents New Data from Phase 3 Trial Evaluating Setmelanotide in Patients with Bardet-Biedl Syndrome (BBS) at the Pediatric Endocrine Society (PES) 2022 Virtual Annual Meeting
— New data show setmelanotide treatment led to clinically meaningful improvements in lipid parameters, without…
Motus GI Announces Upcoming Presentation of Topline Data from the EU Study of the Pure-Vu System at Digestive Disease Week 2022
FORT LAUDERDALE, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Seventh Consecutive Year
MISSISSAUGA, Ontario, May 02, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is…
Intercept to Announce First Quarter 2022 Financial Results on May 6, 2022
MORRISTOWN, N.J., May 02, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company…
Pliant Therapeutics Announces Multiple Presentations at the 2022 American Thoracic Society International Conference
Five posters include data across biomarker, target engagement, and mechanism studies supporting development of PLN-74809,…
Enlivex Announces Upcoming Poster Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
Nes-Ziona, Israel, May 02, 2022 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Medicenna Announces New Clinical Data Showing Dose-Dependent Stimulation of Anti-Cancer Immune Cells with MDNA11 in the Phase 1/2 ABILITY Study
— Levels of Ki67+ expression by CD8+T cells and NK cells increased by 17-fold and…
Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results
MALVERN, Pa., May 02, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company…
Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer
Imagene AI team Imagene Founders Jonathan Zalach, Dean Bitan and Shahar Porat, Chief Scientific Officer…
Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candidates to Endo Ventures Limited
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) — Nevakar Injectables Inc. (“Nevakar”), a wholly owned…
Atsena Therapeutics Announces Presentations at ARVO 2022 Annual Meeting and ASGCT 25th Annual Meeting
Presentations to feature laterally spreading capsid for the treatment of X-linked retinoschisis and dual vector…
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering Conference
Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for…
Akero Therapeutics to Present at Upcoming Healthcare Conferences in May
SOUTH SAN FRANCISCO, May 02, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company…